APPLICATION
ANDA206074
TYPE
ANDA
ORIGINAL APPROVAL
2017-11-24
LATEST ACTION
2020-08-06
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
TOPOTECAN HYDROCHLORIDEDiscontinued
TOPOTECAN HYDROCHLORIDE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2020-08-06Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.